Skip to content

Public FDA record

Z-2662-2014: ADVIA Centaur Immunoassay System, Catalog Numbers/Siemens Material Numbers (SMN) 10284980, 10286140, 1030

Recall record Z-2662-2014 for Siemens Healthcare Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2662-2014
Company in FDA record
Siemens Healthcare Diagnostics
FDA classification date
Sep 18, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The firm is conducting a field correction for the ADVIA Centaur and ADVIA Centaur XP Immunoassay systems, regarding manually loaded sample racks that are improperly loaded or pushed too far on the sample entry queue during normal operation of the ADVIA Centaur and ADVIA Centaur XP Immunoassay systems. Pushing the sample racks may cause misreads of Sample IDs (SID) if the sample rack loading instructions are not followed exactly as described in the ADVIA Centaur or ADVIA Centaur XP Operators Guide.

Source facts

Action
The firm, Siemens, sent "Urgent Medical Device Correction" Letters (dated 8/13/2014) to their consignees/customers informing them of the issue and actions to be taken. Field service personnel were sent a Support Bulletin describing the issue and instructing them how to deal with customer questions. The UFSN must be used by customers as an addendum to the system operating instructions until further notice. The consignees/customers were also instructed to review this letter with your Medical Director; complete and return the attached FIELD CORRECTION EFFECTIVENESS CHECK within 30 days via fax to the Customer Care Center at (302) 631-7597; retain the letter with your laboratory records and forward the letter to those who may have received this product. If you have any questions, please contact your Siemens Customer Care Center, your local Siemens technical support representative and/or call 914-524-2868.
Initiated
2014-08-13
Root cause
Software design (manufacturing process)
Terminated
2017-05-02
Distribution
Worldwide Distribution: US (nationwide) and countries of: Argentina, Austria, Australia, Bahrain, Bangladesh, Belgium, Belgrade, Brazil, Botswana, Canada, Chile, China, Colombia, Croatia, Czech Republic, Cyprus, Denmark, Egypt, Estonia, Finland, France, Germany, Georgia, Great Britain, Hungary, Indonesia, India, Ireland, Israel, Italy, Japan, Jordan, Korea, Kazakstan, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Malaysia, Malta, Martinique, Mexico, Myanmar, New Caledonia, Netherlands, Norway, New Zealand, Pakistan, French Polynesia, Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, Slovakia, South Africa, Spain, Switzerland, Thailand, Turkey, United Arab Emirates, Vatican, Venezuela, Vietnam, Yemen, and Zimbabwe.
Recall number
Z-2662-2014
Recall status
Terminated
CDRH record ID
129577
FDA classified
2014-09-18
Recall event number
69074

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗